Insight Molecular Diagnostics Inc. Revenue 2020–2025
Insight Molecular Diagnostics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Insight Molecular Diagnostics Inc. revenue for the quarter ending March 31, 2026 was 32000, a 98.50% decrease year-over-year.
- Insight Molecular Diagnostics Inc. revenue for the twelve months ending March 31, 2026 was 2.9 M, a 257.77% increase year-over-year.
- Insight Molecular Diagnostics Inc. annual revenue for 2025 was 4.1 M, a 115.58% increase from 2024.
- Insight Molecular Diagnostics Inc. annual revenue for 2024 was 1.9 M, a 25.15% increase from 2023.
- Insight Molecular Diagnostics Inc. annual revenue for 2023 was 1.5 M, a 56.89% increase from 2022.
- Insight Molecular Diagnostics Inc. annual revenue for 2022 was 958000.
Insight Molecular Diagnostics Inc. (IMDX) — Frequently Asked Questions
Insight Molecular Diagnostics Inc. (IMDX) is a publicly traded US company. It has a market capitalization of $176M. In fiscal 2025 it reported revenue of $4M and net income of -$50M. Explore IMDX's stock price, financial statements, earnings history, margins and key ratios below.
What is Insight Molecular Diagnostics Inc.'s market cap?
Insight Molecular Diagnostics Inc. (IMDX) has a market capitalization of $176M.
What is the IMDX stock price?
IMDX trades at $5.76 (-1.54% on the day).
How much revenue does Insight Molecular Diagnostics Inc. make?
Insight Molecular Diagnostics Inc. reported revenue of $4M in fiscal 2025.
Is IMDX profitable?
In fiscal 2025, Insight Molecular Diagnostics Inc. reported net income of -$50M.